A detailed history of Adams Wealth Management transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Adams Wealth Management holds 11,914 shares of BMY stock, worth $555,549. This represents 0.12% of its overall portfolio holdings.

Number of Shares
11,914
Holding current value
$555,549
% of portfolio
0.12%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Sep 25, 2025

BUY
$44.12 - $59.6 $525,645 - $710,074
11,914 New
11,914 $551,000
Q4 2020

Feb 08, 2021

SELL
$57.74 - $65.43 $119,059 - $134,916
-2,062 Closed
0 $0
Q3 2020

Nov 12, 2020

BUY
$57.43 - $63.64 $118,420 - $131,225
2,062 New
2,062 $124,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $99.1B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Adams Wealth Management Portfolio

Follow Adams Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Adams Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Adams Wealth Management with notifications on news.